FILE PHOTO: A test tube labelled with the vaccine is seen in front of AstraZeneca logo in this illustration taken (Reuters) - AstraZeneca Plc <AZN.L> said on Friday it would sell commercial rights for ...
Cheplapharm will pay AstraZeneca a total of $400m in non-contingent consideration, of which the present value will be recognised as Other Operating Income upon completion of the transaction, ...
(Reuters) - AstraZeneca Plc said on Friday it would sell commercial rights for two of its drugs to a German pharmaceutical company for $400 million as the British drugmaker looks to focus on newer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback